Skip to content
Review Open access

Obesity and Cardiovascular Diseases: CVIA State-of-the-Art Review

2026 · Cardiovascular Innovations and Applications · Vol 11 · 0 citations · 192 references

TL;DR

This comprehensive review systematically synthesizes clinical and basic research progress in elucidating the complex relationship between obesity and CVDs and discusses future research directions, including precision medicine, exploration of novel therapeutic targets, and single-cell spatiotemporal omics.

Abstract

Obesity, given its strong association with cardiovascular diseases (CVDs), is a major global public health issue attracting increasing attention. This comprehensive review systematically synthesizes clinical and basic research progress in elucidating the complex relationship between obesity and CVDs. We explore the epidemiology, pathophysiology, clinical manifestations, and management strategies for obesity-related CVDs. Drawing on recent studies, we highlight the effects of obesity on atherosclerotic disease, cardiomyopathy, heart failure, arrhythmias, hypertension, and venous thromboembolism. Understanding these mechanisms is essential for developing effective prevention and treatment strategies to decrease the cardiovascular burden associated with obesity. Furthermore, this review summarizes current therapeutic approaches for obesity-related CVDs, such as lifestyle interventions, pharmacotherapy, and metabolic surgery, and discusses future research directions, including precision medicine, exploration of novel therapeutic targets, and single-cell spatiotemporal omics.

Read PDF

Similar papers

Review

15 HYPERTENSION: A COMPREHENSIVE REVIEW

The findings support the implementation of patient centered models of care that integrate individualized pharmacological treatment, sustainable lifestyle modifications, health education, continuous clinical follow up, and multidisciplinary healthcare teams to optimize blood pressure control, reduce cardiovascular compl...

Unknown authors · 0 citations
Review Aug 2026

The role of preventive cardiology in children.

This review examines aspects of CVH that are commonly managed in preventive cardiology programs, focusing on diagnostic evaluation and treatment strategies, highlighting new and emerging therapies for children and adolescents, including pharmacotherapy and latest research on effective lifestyle modifications.

M. Degen, Shannon M. Lyon · 0 citations
Review Open access Aug 2026

Epicardial adipose tissue and cardiovascular disease: biology, imaging biomarkers, and therapeutic opportunities

Cardiovascular diseases (CVDs) are characterized by high morbidity and mortality rates. Recent studies highlight the significance of epicardial adipose tissue (EAT) in the pathophysiology of coronary artery disease (CAD), arrhythmias, and heart failure (HF), primarily through its direct effects on cardiac structure and...

Jing Zhang, Ziyu An, Hanzhong Luo et al. · 0 citations
Review Open access Aug 2026

Obesity, lipids, inflammation, and healthy aging.

Cardiovascular disease (CVD) is the leading cause of death and disability globally. Thus, prevention efforts aimed at reducing CVD events allow for greater functional independence and wellbeing over the course of life. Low-density lipoprotein-cholesterol is causally associated with atherosclerosis and is the primary ta...

R. Rikhi, Michael D. Shapiro · 0 citations
Review Open access Sep 2026

Anti-diabetic effect in patients with hypertension and liver disease: An integrated therapeutic perspective

Comorbidity, defined as the coexistence of multiple chronic diseases, has become a major concern in global healthcare. Among the clinically significant comorbid conditions, diabetes mellitus, hypertension, and liver disease, particularly non-alcoholic fatty liver disease (NAFLD), represent a complex and interrelated pa...

Jeewanjot Singh, Prabhjot Singh, Subhi Sharma · 0 citations
Review Open access Sep 2026

PHYSICAL ACTIVITY AND DIGITAL HEALTH IN CHRONIC INFLAMMATORY DISEASES: STRATEGIES FOR CARDIOVASCULAR PREVENTION AND IMPROVED HEALTH OUTCOMES

Background. Chronic inflammatory diseases are increasingly recognized as important contributors to cardiovascular morbidity and mortality. Persistent systemic inflammation, endothelial dysfunction, and accelerated atherosclerosis contribute to cardiovascular complications in autoimmune and chronic inflammatory disorder...

Zuzanna Rak, A. Wielogórska, K. Dzień et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.